Whole-Exome Sequencing (WES) of Cancer Patients

Clinical trial NCT02127359 · COMPLETED

Trial details

NCT number: NCT02127359
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Adenocarcinoma Colon Adenocarcinoma

Start date: 2012-09-01
Primary completion: 2017-04-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.